PepGen Inc.
Filed with the SEC on · accession 0001193125-26-454469
PEPG filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +143.7% by the first close after the filing.
PepGen Inc. announced positive Phase 2 FREEDOM2-DM1 10mg/kg results demonstrating the highest reported splicing correction and improvements across multiple functional measures, alongside its third quarter 2026 financial results.
Close before
$2.39
Nov 9, 2026
First close after
+143.72%
$5.83
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PEPG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PEPG?
Click herePEPG filed a 8-K (Fda approval). PepGen Inc. announced positive Phase 2 FREEDOM2-DM1 10mg/kg results demonstrating the highest reported splicing correction and improvements across multiple functional measures, alongside its third quarter 2026 financial results.
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
PEPG closed at $2.39 before the filing and $5.83 on Nov 10, 2026 (+143.72%).
Get alerts when PEPG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days